Physician profile
Howard N Tarkin
NPI 1710980404
$39,321.13
in general payments reported to CMS, 2019-2025
39 companies · $5,883 in 2025
The $5,883 reported for 2025 was more than what 92% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11K · 2020: $2,228 · 2021: $11K · 2022: $3,389 · 2023: $3,034 · 2024: $3,357 · 2025: $5,883.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $11K · Travel and Lodging: $1,501.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $10,772.78 |
| Travel and Lodging | $1,500.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $20,065.22 | 2019-2025 | Watchman Flx, Bodyguardian, Watchman Access System |
| Medtronic, INC. | $4,707.77 | 2021-2025 | Micra, Linq II, Cobalt Dr Mri Surescan |
| Abbott Laboratories | $3,580.81 | 2019-2025 | Jot Dx, Accent, Tendril |
| Medtronic Vascular, INC. | $2,042.58 | 2019-2020 | |
| Amgen INC. | $1,069.53 | 2019-2025 | Repatha |
| Boehringer Ingelheim Pharmaceuticals, INC. | $932.60 | 2019-2024 | Jardiance |
| Janssen Pharmaceuticals, INC | $792.53 | 2019-2024 | Xarelto |
| Abiomed | $763.46 | 2023-2025 | Impella |
| Inspire Medical Systems, INC. | $584.95 | 2024-2025 | Inspire |
| Novartis Pharmaceuticals Corporation | $486.22 | 2019-2024 | |
| Astrazeneca Pharmaceuticals LP | $481.05 | 2019-2024 | Farxiga |
| Novo Nordisk INC | $386.50 | 2020-2021 | |
| Biotronik INC. | $350.56 | 2019-2024 | Acticor 7 Vr-T Dx |
| Genzyme Corporation | $321.80 | 2019-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $289.56 | 2019-2025 | Lifevest |
Show all 39 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Howard Tarkin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.